| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 1, 2014- Record 665 HeartWare® Ventricular Assist Systems sold worldwide in Q1; exceeds previous quarterly high of 549 units
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Apr 18, 2014New Clinical Data from PANDORA and ENGAGE Affirm
MINNEAPOLIS -- April 18, 2014 -- The Endurant AAA stent graft system from Medtronic, Inc. (NYSE: MDT) continues to demonstrate exceptional long-term performance in the endovascular treatment of...
-
Apr 11, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Apr. 11, 2014-- Covidien plc today announced that it has notified customers of a voluntary recall to address an issue with certain lots of its Pipeline™...
-
Apr 10, 2014
MINNEAPOLIS - April 10, 2016 - This weekend, an article was published in the Minneapolis Star Tribune that criticized Medtronic's handling of data collected during a retrospective chart review...
-
Apr 5, 2014Interventional Treatment of Lower-Extremity Peripheral Arterial Disease With Novel Medical Device Shows Positive Results in IN.PACT SFA Trial
LONDON -- April 5, 2014 --Patients with peripheral artery disease in the upper leg experienced significantly better outcomes at 12 months after treatment with the IN.PACT Admiral drug-coated...
-
Mar 30, 2014Six-Month Analysis of First 1,000 Patients Enrolled in Real-World Patient Registry Presented at ACC.14
MINNEAPOLIS and WASHINGTON, D.C. - March 30, 2014 - Medtronic, Inc. (NYSE: MDT), announced today further analysis of six-month follow-up data from the first 1,000 patients enrolled in the Global...
-
Mar 30, 2014Has Repaired Hearts of 6,000+ Patients; More Than Half Are Children
MINNEAPOLIS and WASHINGTON - March 30, 2014 - Medtronic, Inc. (NYSE: MDT), today announced the one-year results of the Melody® Transcatheter Pulmonary Valve (TPV) U.S. Post-Approval Study, which...
-
Mar 29, 2014Medtronic CoreValve® System Results Superior to Open-Heart Surgery at One Year in U.S. Pivotal TrialCoreValve High Risk Study: FDA Determines Expert Panel Not Required
MINNEAPOLIS and WASHINGTON - March 29, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that the CoreValve® System showed results superior to surgical aortic valve replacement (SAVR) at one...
-
Mar 29, 2014Medtronic Commits to Further Clinical Investigation and Determining Path Forward for Next U.S. IDE with FDA
MINNEAPOLIS and WASHINGTON, DC - March 29, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the full results of the SYMPLICITY HTN-3 clinical trial, which were presented today in late-breaking...
-
Mar 10, 2014"Global Heroes" Receive Entry and Travel to the Medtronic Twin Cities Marathon or Medtronic TC 10 Mile in October
MINNEAPOLIS - March 10, 2014 - Medtronic, Inc. (NYSE: MDT) announced today applications are open to runners around the world who benefit from medical technology to represent their country on the...